skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Antiviral Therapy remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The renal-bone axis in older people living with HIV on stable antiretroviral therapy: A sub-analysis of the GS-US-104-0423 study
The renal-bone axis in older people living with HIV on stable antiretroviral therapy: A sub-analysis of the GS-US-104-0423 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

The renal-bone axis in older people living with HIV on stable antiretroviral therapy: A sub-analysis of the GS-US-104-0423 study

Alvarez, Elena ; Campbell, Lucy ; Tinago, Willard ; Garcia-Leon, Alejandro ; Walsh, Ian ; Brady, Jennifer J ; Burling, Keith ; Noe, Sebastian ; Neuville, Marie F ; Jouret, Francois ; Jamshidian, Farid ; Graham, Hiba ; Rhee, Martin ; Mallon, Paddy W ; Post, Frank A

Antiviral therapy, 2022-08, Vol.27 (4), p.135965352210948-13596535221094898 [Periódico revisado por pares]

London, England: SAGE Publications

Texto completo disponível

Citações Citado por
2
Treatment-related early discontinuations and adverse events among newly diagnosed people living with HIV initiating integrase inhibitors in a real-world setting
Treatment-related early discontinuations and adverse events among newly diagnosed people living with HIV initiating integrase inhibitors in a real-world setting
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment-related early discontinuations and adverse events among newly diagnosed people living with HIV initiating integrase inhibitors in a real-world setting

Rolle, Charlotte-Paige ; Castano, Jamie ; Nguyen, Vu ; Patel, Kiran ; Hinestrosa, Federico ; DeJesus, Edwin

Antiviral therapy, 2023-02, Vol.28 (2), p.13596535231163703-13596535231163703 [Periódico revisado por pares]

London, England: SAGE Publications

Texto completo disponível

Citações Citado por
3
Adverse drug reactions attributed to generic substitution of antiretroviral medications among HIV treatment and pre-exposure prophylaxis clients in British Columbia, Canada
Adverse drug reactions attributed to generic substitution of antiretroviral medications among HIV treatment and pre-exposure prophylaxis clients in British Columbia, Canada
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adverse drug reactions attributed to generic substitution of antiretroviral medications among HIV treatment and pre-exposure prophylaxis clients in British Columbia, Canada

Lepik, Katherine J ; Hunt, Olivia L ; Bacani, Nic ; Wang, Lu ; Harris, Marianne ; Toy, Junine ; McLinden, Taylor ; Sereda, Paul ; Akagi, Linda J ; Ready, Erin ; Montaner, Julio SG ; Barrios, Rolando

Antiviral therapy, 2024-02, Vol.29 (1), p.13596535241233128-13596535241233128 [Periódico revisado por pares]

London, England: SAGE Publications

Texto completo disponível

Citações Citado por
4
Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts
Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts

de Waal, Reneé ; Rabie, Helena ; Technau, Karl-Günter ; Eley, Brian ; Sipambo, Nosisa ; Cotton, Mark ; Boulle, Andrew ; Wood, Robin ; Tanser, Frank ; Fatti, Geoffrey ; Egger, Matthias ; Davies, Mary-Ann

Antiviral therapy, 2023-04, Vol.28 (2), p.13596535231168480-13596535231168480 [Periódico revisado por pares]

London, England: SAGE Publications

Texto completo disponível

Citações Citado por
5
An unexpected adverse effect: Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide–induced cholestasis
An unexpected adverse effect: Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide–induced cholestasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

An unexpected adverse effect: Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide–induced cholestasis

Ugarte, Ainoa ; De la Mora, Lorena ; Martínez-Rebollar, María ; Mallolas, Josep ; Laguno, Montserrat

Antiviral therapy, 2021-01, Vol.26 (1-2), p.9-12 [Periódico revisado por pares]

London, England: SAGE Publications

Texto completo disponível

Citações Citado por
6
Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D
Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D
Material Type:
Artigo 		Adicionar ao Meu Espaço

Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D

BROWN, Todd T ; MCCOMSEY, Grace A

Antiviral therapy, 2010, Vol.15 (3), p.425-429 [Periódico revisado por pares]

London: International Medical Press

Texto completo disponível

Citações Citado por
7
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in antiretroviral-experienced subjects: week 48 analysis of AI438011, a Phase IIb, randomized controlled trial
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in antiretroviral-experienced subjects: week 48 analysis of AI438011, a Phase IIb, randomized controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in antiretroviral-experienced subjects: week 48 analysis of AI438011, a Phase IIb, randomized controlled trial

Thompson, Melanie ; Lalezari, Jacob P ; Kaplan, Richard ; Pinedo, Yvett ; Pena, Otto A Sussmann ; Cahn, Pedro ; Stock, David A ; Joshi, Samit R ; Hanna, George J ; Lataillade, Max

Antiviral therapy, 2017-01, Vol.22 (3), p.215-223 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
8
Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral―naive HIV-1 patients: the ARTEN Trial
Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral―naive HIV-1 patients: the ARTEN Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral―naive HIV-1 patients: the ARTEN Trial

SORIANO, Vicente ; ARASTEH, Keikawus ; DOMINGO, Pere ; GELLERMANN, Holger ; DE ROSSI, Lothar ; MIGRONE, Horacio ; LUTZ, Thomas ; OPRAVIL, Milos ; ANDRADE-VILLANUEVA, Jaime ; ANTUNES, Francisco ; DI PERRI, Giovanni ; PODZAMCZER, Daniel ; TAYLOR, Steve

Antiviral therapy, 2011-01, Vol.16 (3), p.339-348 [Periódico revisado por pares]

London: International Medical Press

Texto completo disponível

Citações Citado por
9
Effects on vitamin D, bone and the kidney of switching from fixed-dose tenofovir disoproxil fumarate/emtricitabine/efavirenz to darunavir/ritonavir monotherapy: a randomized, controlled trial (MIDAS)
Effects on vitamin D, bone and the kidney of switching from fixed-dose tenofovir disoproxil fumarate/emtricitabine/efavirenz to darunavir/ritonavir monotherapy: a randomized, controlled trial (MIDAS)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects on vitamin D, bone and the kidney of switching from fixed-dose tenofovir disoproxil fumarate/emtricitabine/efavirenz to darunavir/ritonavir monotherapy: a randomized, controlled trial (MIDAS)

Hamzah, Lisa ; Tiraboschi, Juan M ; Iveson, Helen ; Toby, Martina ; Mant, Christine ; Cason, John ; Burling, Keith ; Wandolo, Emily ; Jendrulek, Isabelle ; Taylor, Chris ; Ibrahim, Fowzia ; Kulasegaram, Ranjababu ; Teague, Alastair ; Post, Frank A ; Fox, Julie

Antiviral therapy, 2016-01, Vol.21 (4), p.287-296 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
10
Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir
Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir
Material Type:
Artigo 		Adicionar ao Meu Espaço

Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir

BIFANO, Marc ; HWANG, Carey ; OOSTERHUIS, Berend ; HARTSTRA, Jan ; GRASELA, Dennis ; TIESSEN, Renger ; VELINOVA-DONGA, Maria ; KANDOUSSI, Hamza ; SEVINSKY, Heather ; BERTZ, Richard

Antiviral therapy, 2013-01, Vol.18 (7), p.931-940 [Periódico revisado por pares]

London: International Medical Press

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.